Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
FDA Authorizes New COVID Boosters for Kids
01:52pm, Wednesday, 12'th Oct 2022
Like Moderna's and Pfizer's updated vaccines for adults, the child doses target newer strains of COVID-19.
Moderna, Merck to jointly develop cancer vaccine
12:21pm, Wednesday, 12'th Oct 2022
Yahoo Finance Live's Julie Hyman discusses the rise in shares for Merck and Moderna after Moderna announced the joint development and potential sale of an mRNA-based cancer vaccine.
Why Moderna Stock Is Bolting Higher Today
11:24am, Wednesday, 12'th Oct 2022
A cancer vaccine deal with pharma heavyweight Merck is lighting a fire underneath the biotech's shares today.
Why Is Moderna (MRNA) Stock Up 10% Today?
11:23am, Wednesday, 12'th Oct 2022
Could this be a collaboration that saves lives? That's the billion-dollar question today as Moderna (NASDAQ: MRNA ) is reportedly working with Merck (NYSE: MRK ) to develop an mRNA-based cancer vaccin
FDA said children between 6 and 17 can get Moderna's new COVID-19 booster
10:47am, Wednesday, 12'th Oct 2022
Shares of Moderna Inc. MRNA, +8.93% soared 9.4% in trading on Wednesday after the Food and Drug Administration said children between the ages of 6 and 17 years old can now get the bivalent COVID-19 bo
Merck partners with Moderna to develop a cancer vaccine
10:42am, Wednesday, 12'th Oct 2022
CNBC's Jim Cramer and the 'Squawk on the Street' team discuss Merck's decision to develop a cancer vaccine with mRNA developer Moderna.
Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients
10:07am, Wednesday, 12'th Oct 2022
Moderna's vaccine is being studied in combination with Merck's Keytruda to treat patients with high-risk melanoma, the deadliest form skin cancer.
Moderna Surges As Merck Inks Deal To Co-Develop Personalized Cancer Vaccine Treatment
09:23am, Wednesday, 12'th Oct 2022
Merck opted Wednesday to help Moderna develop a personalized cancer vaccine based on messenger RNA technology, and MRNA stock rocketed. The post Moderna Surges As Merck Inks Deal To Co-Develop Persona
10 Fallen Growth Stocks Will Make You Up To 113% Richer, Analysts Say
08:00am, Wednesday, 12'th Oct 2022
Seeing S&P 500 growth stocks implode is tough to watch, unless you're ready to spot a buy point. The post 10 Fallen Growth Stocks Will Make You Up To 113% Richer, Analysts Say appeared first on Invest
Merck, Moderna to develop personalized cancer vaccine
07:47am, Wednesday, 12'th Oct 2022
Merck & Co. Inc. MRK, +0.63% and Moderna Inc. MRNA, -2.19% said Wednesday that they plan to jointly develop and commercialize a personalized cancer vaccine. The investigational vaccine is currently be
Smart Investors Will Be Buying All the Dips for These 7 Stocks
02:39pm, Monday, 10'th Oct 2022
Although the red ink splashed on the equities sector has many bulls in the dumps, it's also important to remember that the doldrums open opportunities for these 7 stocks to buy on the dip. To be fair,
Better Buy: Moderna vs. Axsome Therapeutics
06:00am, Monday, 10'th Oct 2022
Both of these biotechs offer exciting future prospects.
Get Ready for the Next Bull Market: 3 Stocks to Buy Right Now
06:00am, Friday, 07'th Oct 2022
These leaders look cheap, considering their growth prospects.
Why Moderna Stock Couldn't Shake the Thursday Blues
06:35pm, Thursday, 06'th Oct 2022
The CDC's latest report on COVID-19 vaccinations didn't provide enough fuel for shareholder optimism.
Moderna: A Great Diversification Into Large Cap
11:04am, Monday, 03'rd Oct 2022
As a $48B market cap company, Moderna delivers a highly efficacious/safe vaccine for COVID. The company is also advancing a pipeline of both vaccines and therapeutics that are highly promising.
